Have the rumours topical as far back as in autumn 2008 about the delay of implementation of the medication manufacture obligatory responsibility to the requirements of the Due production practice proved true since 2009? In the article you can find analysis of regulations and decrees in the pharmaceutical branch. Authors also suggest their own perspective of the outcomes of such “policy” and some recommendation concerning the situation at hand.

A lot of examples of efficient advertising don’t at all sit consumers loose due to the “shock therapy” method. Different provocative images, scandalous videos, intriguing or ambiguous audio tracks - that is everything bound to arouse problems with the purview.

Having adopted some new resolutions, the content of which is hardly different from the previous resolutions No 827 “About the waiver of the State service of medical products and remedies” and No 837 “An issue of performing the state quality control of medical products” (whose functioning has been earlier suspended), the Cabinet of ministers has vacated the provisions of the Resolution No 837 without waiting for the Constitutional Court verdict. And although this step has been predicted, it was sure not to be embraced as a New Year present by the industry. So what has really happened and what are the outcomes of all that?